NEWS

Sim&Cure achieves CE Marking for Sim&Size product under New Medical Devi...

Montpellier, 2024/03/11 – Sim&Cure, a leading innovator in the neurovascular field, is proud to announce that its innovative Sim&Size™ product has once more attained CE Certification, this time in accordance with the latest Medical Device Regulation (EU MDR 2017/745), underscoring our commitment to meeting evolving regulatory standards.

Honoring INR experts: Celebrating IWD 2024!

Aristotle®-Only ADAPT: Macrowires for ischemic stroke

M1 Fenestration aneurysm with early origin of the MCA

Embolization for Basal Ganglia AVMs

Day 2: Strengthening the foundations of INR Practice

Day 1 - Where the world of INR comes together!

'INR Stories: The Uncensored Interview'. Podcast episode 4!

'INR Stories: The Uncensored Interview'. Podcast episode 5!

Sensome announces initiation of clinical trial assessing its tissue micr...

PARIS, FRANCE - FEBRUARY 12TH, 2024 – Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today enrollment of the first patients into a feasibility clinical study using the Clotild® Smart Guidewire in peripheral artery disease (PAD). Clotild® was designated a breakthrough medical device for use in brain arteries by the FDA in 2021.